This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

View quarterly trends in Risky Prescribing Measures, including:
o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the location of the prescriber seen by a patient meeting these criteria.
o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the individual’s county of residence.
o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions per 1,000 Population: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence.
Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

State Health Centers information.

This dataset contains counts of COVID-19 deaths by ethnicity by county. Suppression applies for quantities less than 5.

Data only includes information reported to EDRS, the Electronic Death Reporting System.
Data usually updated each Friday.

This indicator includes the count and rate of newly diagnosed cases of Hepatitis C per 1,000 individuals estimated to have Drug Use Disorder.

This indicator includes the count and rate of newly diagnosed cases of HIV through injection drug use per 100,000 individuals estimated to have Drug Use Disorder.

This indicator includes the count and rate of newly diagnosed cases of Hepatitis C per 1,000 individuals estimated to have Drug Use Disorder.

This dataset contains aggregate COVID-19 case counts by race by county of first report for all counties in Pennsylvania. Counts include both confirmed and probable cases as defined by the Council of State and Territorial Epidemiologists (CSTE).
Suppression applies for quantities 1-4.

Data only includes information reported to PA-NEDSS, Pennsylvania National Electronic Disease Surveillance System.

This dataset contains aggregate COVID-19 case counts by gender by county of first report for all counties in Pennsylvania. Counts include both confirmed and probable cases as defined by the Council of State and Territorial Epidemiologists (CSTE).
Suppression applies for quantities 1-4.

Data only includes information reported to PA-NEDSS, Pennsylvania National Electronic Disease Surveillance System.

This indicator includes the count and rate of new HIV diagnoses among individuals using injection drugs per 100,000 individuals estimated to have Drug Use Disorder.